160 related articles for article (PubMed ID: 37014269)
21. Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer.
Rouette J; Yin H; Pottegård A; Nirantharakumar K; Azoulay L
Drug Saf; 2021 Feb; 44(2):245-254. PubMed ID: 33104975
[TBL] [Abstract][Full Text] [Related]
22. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
Pandeya N; Olsen CM; Thompson BS; Dusingize JC; Neale RE; Green AC; Whiteman DC;
Br J Dermatol; 2019 Oct; 181(4):749-760. PubMed ID: 30920641
[TBL] [Abstract][Full Text] [Related]
23. Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study.
Drucker AM; Hollestein L; Na Y; Weinstock MA; Li WQ; Abdel-Qadir H; Chan AW
CMAJ; 2021 Apr; 193(15):E508-E516. PubMed ID: 33846199
[TBL] [Abstract][Full Text] [Related]
24. The use of HCT and/or ACE inhibitors significantly increases the risk of non-melanotic skin cancer in the periocular region.
Mehlan J; Ueberschaar J; Hagenström K; Garbe C; Spitzer MS; Druchkiv V; Schuettauf F
Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2745-2751. PubMed ID: 35175408
[TBL] [Abstract][Full Text] [Related]
25. Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study.
Azoulay L; St-Jean A; Dahl M; Quail J; Aibibula W; Brophy JM; Chan AW; Bresee L; Carney G; Eltonsy S; Tamim H; Paterson JM; Platt RW;
J Am Acad Dermatol; 2023 Aug; 89(2):243-253. PubMed ID: 37105517
[TBL] [Abstract][Full Text] [Related]
26. Hydrochlorothiazide Use and Skin Cancer: A Mohs Surgeon's Concern.
Cognetta AB; Wolfe CM; Heinrichs E
Dermatol Surg; 2016 Sep; 42(9):1107-9. PubMed ID: 27243134
[No Abstract] [Full Text] [Related]
27. The association of metformin use with keratinocyte carcinoma development in high-risk patients.
Misitzis A; Stratigos AJ; Beatson M; Mastorakos G; Dellavalle RP; Weinstock MA;
Dermatol Ther; 2020 Nov; 33(6):e14402. PubMed ID: 33047438
[TBL] [Abstract][Full Text] [Related]
28. Statin Use and Skin Cancer Risk: A Prospective Cohort Study.
Al Rahmoun M; Ghiasvand R; Cairat M; Mahamat-Saleh Y; Cervenka I; Severi G; Boutron-Ruault MC; Robsahm TE; Kvaskoff M; Fournier A
J Invest Dermatol; 2022 May; 142(5):1318-1325.e5. PubMed ID: 34695411
[TBL] [Abstract][Full Text] [Related]
29. Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: A systematic review and meta-analysis.
de Macedo Andrade AC; Felix FA; França GM; Ribeiro ILA; Barboza CAG; de Castro RD; de Lisboa Lopes Costa A
Eur J Clin Pharmacol; 2022 Jun; 78(6):919-930. PubMed ID: 35258665
[TBL] [Abstract][Full Text] [Related]
30. The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study.
de Haan-Du J; Landman GWD; Groenier KH; Vissers PAJ; Louwman MWJ; Kleefstra N; de Bock GH
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2114-2121. PubMed ID: 34493493
[TBL] [Abstract][Full Text] [Related]
31. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
Katz KA; Marcil I; Stern RS
J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
[TBL] [Abstract][Full Text] [Related]
32. Use of hydrochlorothiazide and risk of nonmelanoma skin cancer: a pilot study in the Brazilian population.
Tiba APL; Cury-Martins J; Miyashiro DR; Sanches JA
Int J Dermatol; 2022 Jun; 61(6):e213-e214. PubMed ID: 34480765
[No Abstract] [Full Text] [Related]
33. Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.
Scott JF; Brough KR; Grigoryan KV; Muzic JG; Kim GY; Conic RRZ; Hill ST; Brewer JD; Baum CL; Litzow MR; Hogan WJ; Patnaik MS; Hashmi SK; Lazarus HM; Bordeaux JS; Thompson CL; Gerstenblith MR; Lehman JS
JAMA Dermatol; 2020 Jun; 156(6):631-639. PubMed ID: 32267479
[TBL] [Abstract][Full Text] [Related]
34. The effect of hydrochlorothiazide on the recurrence of nonmelanoma skin cancer: a 7-year retrospective study comprising 300 patients.
Özkan B; Savran S; Akıncı K; Albayati A; Uysal Pİ; Uysal AÇ
Turk J Med Sci; 2023 Jun; 53(3):760-752. PubMed ID: 37476909
[TBL] [Abstract][Full Text] [Related]
35. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
36. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
Stenz NA; Stampf S; Arnold AW; Cozzio A; Dickenmann M; Gaide O; Harms M; Hunger RE; Laffitte E; Mühlstädt M; Nägeli M; Hofbauer GFL;
Dermatology; 2021; 237(6):970-980. PubMed ID: 33227788
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Queensland, Australia.
Claeson M; Pandeya N; Dusingize JC; Thompson BS; Green AC; Neale RE; Olsen CM; Whiteman DC
JAMA Dermatol; 2020 Dec; 156(12):1324-1332. PubMed ID: 33026421
[TBL] [Abstract][Full Text] [Related]
38. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
39. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
Neugebauer R; Su KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM
J Am Acad Dermatol; 2019 Apr; 80(4):998-1005. PubMed ID: 30458208
[TBL] [Abstract][Full Text] [Related]
40. Use of antihypertensive drugs and risk of skin cancer.
Schmidt SA; Schmidt M; Mehnert F; Lemeshow S; Sørensen HT
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1545-54. PubMed ID: 25640031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
